Subcutaneous phaeohyphomycosis (mycotic cyst).
Phaeohyphomycosis designates fungal infections caused by pheoid or melanized fungi and characterized histopathologically by the presence of septate hyphae, pseudohyphae, and yeasts. Etiologic agents include Exophiala, Phoma, Bipolaris, Phialophora, Colletotrichum, Curvularia, Alternaria, Exserohilum, and Phialemonium sp. The most common are Exophiala jeanselmei and Wangiella dermatitidis. The clinical presentation depends on the immune status of the host: superficial (tinea nigra and black piedra); cutaneous (scytalidiosis) and corneal; subcutaneous (mycotic cyst); and systemic phaeohyphomycosis in the immunocompromised host. The mycotic cyst is a localized form, characterized by subcutaneous asymptomatic nodular lesions that develop after traumatic implantation of fungi, especially on the extremities. The average size of the cysts is 2.5 cm. KOH examination reveals pigmented yeasts, pseudohyphae, and hyphae. A cutaneous biopsy specimen usually shows an abscess or a suppurative granuloma with pigmented yeasts and pseudohyphae. The treatment of choice is surgical excision, but additional anti-fungal therapy is recommended for recurrent cases and immunocompromised patients.
Instituto Dermatológico y Cirugía de Piel Dr. Huberto Bogaert Díaz, Santo Domingo, Dominican Republic.
Rafael
R
Isa-Isa
Carlos
C
García
Mariel
M
Isa
Roberto
R
Arenas
D000935:Antifungal Agents / Q000627:therapeutic use*; D001706:Biopsy; D003560:Cysts; D003937:Diagnosis, Differential; D006801:Humans; D025301:Hyphae / Q000302:isolation & purification; D016867:Immunocompromised Host; D003904:Mitosporic Fungi / Q000302:isolation & purification*; D060446:Phaeohyphomycosis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D040521:Subcutaneous Tissue / Q000382:microbiology*
D000935:Antifungal Agents